Interestingly, we also observed that p-ERK or p-4E-BP1 were also downregulated to a greater extent in our MM cell lines after the combination treatment of temsirolimus and trametinib compared to each agent alone (Figure 3E and Figure S10); this needs to be interpreted by further experiments. This evidence concerns the gene EIF4EBP1 and Miyoshi myopathy.